We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

138 hedge funds and large institutions have $227M invested in DIPLOMAT PHARMACY, INC. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $536K

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

2% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 43

1% more funds holding

Funds holding: 137138 (+1)

28% less capital invested

Capital invested by funds: $317M → $227M (-$90M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
44
Reduced
43
Closed
34
Calls
$2.56M
Puts
$536K
Net Calls
+$2.03M
Net Calls Change
-$946K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
51
Wells Fargo
California
$472K -$32.9K -7,001 -6%
Swiss National Bank
52
Swiss National Bank
Switzerland
$465K +$25.4K +5,400 +5%
DZ Bank
53
DZ Bank
Germany
$459K
AllianceBernstein
54
AllianceBernstein
Tennessee
$447K +$1.64K +350 +0.3%
SMC
55
S. Muoio & Co
New York
$400K +$470K +100,000 New
CS
56
Credit Suisse
Switzerland
$389K +$194K +41,264 +74%
PPA
57
Parametric Portfolio Associates
Washington
$384K -$593K -126,326 -57%
SCS
58
Syquant Capital SAS
France
$377K +$443K +94,260 New
Prudential Financial
59
Prudential Financial
New Jersey
$369K -$100K -21,348 -19%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$355K -$10.7K -2,271 -2%
IRC
61
Investors Research Corp
Georgia
$352K -$1.64K -350 -0.4%
UBS Group
62
UBS Group
Switzerland
$342K -$4.67M -994,792 -92%
SCM
63
Stevens Capital Management
Pennsylvania
$318K +$373K +79,410 New
VF
64
Virtu Financial
New York
$312K +$366K +77,957 New
Simplex Trading
65
Simplex Trading
Illinois
$300K +$325K +69,114 +1,174%
Walleye Trading
66
Walleye Trading
New York
$299K +$199K +42,436 +132%
Canada Life
67
Canada Life
Manitoba, Canada
$282K +$335K +71,296 New
Bank of America
68
Bank of America
North Carolina
$270K +$46.2K +9,826 +17%
SRAM
69
Stone Ridge Asset Management
New York
$219K
Comerica Bank
70
Comerica Bank
Texas
$213K -$235 -50 -0.1%
ECM
71
Everence Capital Management
Indiana
$211K
Thrivent Financial for Lutherans
72
Thrivent Financial for Lutherans
Minnesota
$184K +$2.42K +516 +1%
AC
73
Aristides Capital
Kentucky
$183K +$215K +45,802 New
Voloridge Investment Management
74
Voloridge Investment Management
Florida
$177K +$208K +44,250 New
Mitsubishi UFJ Trust & Banking
75
Mitsubishi UFJ Trust & Banking
Japan
$175K +$154K +32,700 +295%

DPLO Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2019, worth a combined $227M — down 28% from $317M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new DPLO positions and 34 closed out — a net gain of 1 holder — while 44 added to existing stakes and 43 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $11M. The largest seller was Armistice Capital, exiting entirely with an estimated $26.5M sold.

  • 138 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2019, up from 137 in Q3 2019.
  • Funds reported $227M of DIPLOMAT PHARMACY, INC. stock for Q4 2019, down 28% quarter-over-quarter.
  • 35 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2019 and 34 closed out, a net change of +1 holder.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2019 was Renaissance Technologies, an estimated $11M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2019 was Armistice Capital, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2019.